Tessa Therapeutics Pte Ltd

About Tessa Therapeutics Pte Ltd

Tessa Therapeutics is a clinical stage biopharmaceutical company with the scientific vision of revolutionizing the treatment of cancer by redirecting the body’s potent anti-viral immune response to recognize and kill cancer cells. Tessa’s core virus-specific T cell (VST) platform has shown compelling results in the treatment of solid tumors, and the company is building a portfolio of therapies addressing a wide range of tumors by combining the qualities of its T cell platform with complementary technologies.

YEAR FOUNDED:

2011 

LEADERSHIP:

CEO: Andrew Khoo

COO: John Ng

CFO: Desmond Lim

CLINICAL TRIAL:

Please click here for clinical trial information.